Drugging Our Children: How Profiteers Are Pushing Antipsychotics on Our Youngest, and What We Can Do to Stop It

Drugging Our Children: How Profiteers are Pushing Antipsychotics on Our Youngest, and What We Can Do to Stop It

Volumn , Issue , 2012, Pages 1-234

  Olfman, Sharna ^a   Robbins, Brent Dean ^a  

^a POINT PARK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85189420453     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (485)

1. Spielmans, G. I., Parry, P. I. (2010). From Evidence-Based Medicine toMarketing-Based Medicine: Evidence from Internal Industry Documents. BioethicalInquiry. Retrieved from http://i.bnet.com/blogs/spielmans-parry-ebm-to-mbmjbioethicinqu-2010.pdf
2. Robbins, B. D., Higgins, M., Fisher, M., Over, K. (2011).Confl icts of interest in research on antipsychotic treatment of pediatric bipolar disorder,temper dysregulation disorder, and attenuated psychotic symptoms syndrome:Exploring the unholy alliance between big pharma and psychiatry. Journalof Psychological Issues in Organizational Culture, 1 (4), 32–49.
3. Zito, J. M., Safer, D. J. (2005). Recent Child PharmacoepidemiologicalFindings. Journal of Child and Adolescent Psychopharmacology, 15 (1), 5–9.
4. Olfson, M., Crystal, S., Huang, C., Gerhard, T. (2010). Trends in AntipsychoticDrug Use by Very Young, Privately Insured Children. Journal of the AmericanAcademy of Child & Adolescent Psychiatry, 49 (1), 13–23.
5. Crystal, S., Olfson, M., Huang, C., Pincus, H., Gerhard, T. (2009). BroadenedUse of Atypical Antipsychotics; Safety, Effectiveness, & Policy Challenges.Health Affairs, 28 (5), w770–w781.
6. Gottstein, J. B. (2009, October). Litigating Against the Psychiatric Drugging ofChildren & Youth. ICSPP Annual Conference, Syracuse, NY.
7. Crystal et al., Broadened Use of Atypical Antipsychotics; Duff, W. (2009, December11). Poor Children Likelier to get Antipsychotics. New York Times. Retrievedfrom http://www.nytimes.com/2009/12/12/health/12medicaid.html?_r=1.
8. Whitaker, R. (2002). Mad in America. New York: Basic Books.
9. Waters, R. (2005, May/June). Medicating Aliah. Mother Jones.
10. Whitaker, Mad in America, p. 277.
11. Olfson et al., Trends in Antipsychotic Drug Use.
12. Sheller, S. (2009, October). Keynote Address. ISPP Annual Conference, Syracuse,NY.
13. Olfson et al., Trends in Antipsychotic Drug Use.
14. Healy, D. (2007). Bipolar Syndrome by Proxy? The Case of Pediatric BipolarDisorder. In Sharna Olfman,, Bipolar Children: Cutting Edge Controversy, Insight,and Research. Praeger Press, Westport, CT
15. Healy, D. (2003). Let Them Eat Prozac. Toronto:James Lorimer & Company, pp. 12–13; Whitaker, Mad in America.
16. Diller, L. (2007). But Don’t Call It Science. In Sharna Olfman,, Bipolar Children:Cutting Controversy, Insight, and Research (pp. 28–45). Westport, CT: PraegerPublishers
17. Harris, G. (2009, March 19). Drug Maker Told Studies Would Aid It, PapersSay. New York Times. Retrieved from http://www.nytimes.com/2009/03/22/us/20psych.html
18. Kowalczyk, L. (2009, March 21). Senator broadens inquiry intopsychiatrist. Boston Globe, p. B.1, Metro.
19. Whitaker, Mad in America, p. 281.
20. Healy, D., Le Noury, J. (2007). Bipolar Syndrome by Proxy? The Case ofPediatric Bipolar Disorder. In Sharna Olfman,, Bipolar Children: Cutting Controversy,Insight, and Research, Praeger Publishers. Westport, CT: Praeger Publishers.
21. Olfson et al., Trends in Antipsychotic Drug Use.
22. Olfman, S. (Ed.). (2006). No Child Left Different. Westport, CT: PraegerPublishers.
23. Olfman, S. (Ed.). (2005). Childhood Lost. Westport, CT: Praeger Publishers.
24. Carey, B. (2010, February 10). Revising Book on Disorders of the Mind.New York Times. Retrieved from http://www.nytimes.com/2010/02/10/health/10psych.html.
25. J. Zito, “Psychotropic practice patterns for youth,” Arch Pediatr Adolesc Med 15. (2003): 17–25.
26. C. Moreno, “National trends in the outpatient diagnosis and treatment ofbipolar disorder in youth,” Arch Gen Psychiatry 64 (2007): 1032–39.
27. Deposition of Joseph Biederman in legal case of Avila v. Johnson & JohnsonCo., Feb. 26, 2009, pp. 139, 231, 232, 237.
28. J. Biederman, “Attention-deficit hyperactivity disorder and juvenile mania,”J Am Acad Child & Adolesc Psychiatry 35 (1996): 997–1008.
29. G. Harris, “Researchers fail to reveal full drug pay,” New York Times, June 8,2008.
30. Deposition of Joseph Biederman, p. 119.
31. J. Biederman, Annual Report 2002: The Johnson & Johnson Center for PediatricPsychopathology at the Massachusetts General Hospital.
32. C. Moreno, “National trends.”
33. R. Waters, “J&J, Pfizer Profit on ‘Juvenile Bipolar Juggernaut,’ ” BloombergNews, Sept. 5, 2007.
34. M. Olfson, “National trends in the outpatient treatment of children and adolescentswith antipsychotic drugs,” Arch Gen Psychiatry 63 (2006): 679–85.
35. B. Vitiello, “Antipsychotics in children and adolescents,” Eur Neuropsychopharmacol 1. (2009): 629–35
36. C. Panagiotopoulos, “First do no harm,” J Can AcadChild Adolesc Psychiatry 19 (2010): 124–37.
37. P. Weiden, Breakthroughs in Antipsychotic Medications (New York: W.W. Norton,1999), p. 26.
38. E. Nestler and S. Hyman, Molecular Neuropharmacology (New York: Mc-Graw Hill, 2002), p. 392.
39. H. Nasrallah, “Atypical antipsychotic-induced metabolic side effects,” MolPsychiatry 13 (2008): 27–35.
40. Also see M. DeHert, “Metabolic and endocrine adverse effects ofsecond- generation antipsychotics in children and adolescents,” Eur Psychiatry(2011), doi:10.1016.
41. C. Correll, “Antipsychotic use in children and adolescents,” J Am Acad ChildAdolesc Psychiatry 47 (2008): 9–20.
42. DeHert, “Metabolic and endocrine adverse effects”; Nasrallah, “Atypicalantipsychotic-induced metabolic side effects.”
43. D. Fraguas, “Efficacy and safety of second-generation antipsychotics inchildren and adolescents with psychotic and bipolar spectrum disorders,” EurNeuropsychopharmacol (2010), doi:10.1016.
44. L. Sikich, “Double-blind comparison of first-and second-generation antipsychoticsin early-onset schizophrenia and schizoaffective disorder,” Am J Psychiatry 16. (2008): 1420–31.
45. Vitiello, “Antipsychotics in children and adolescents.”
46. DeHert, “Metabolic and endocrine adverse effects.”
47. Vitiello, “Antipsychotics in children and adolescents.”
48. Panagiotopoulos, “First do no harm.”
49. R. Findling, “Double-blind maintenance safety and effectiveness findingsfrom the treatment of early-onset schizophrenia spectrum (TEOSS) study,” J AmAcad Child & Adolesc Psychiatry 49 (2010): 583–94.
50. NIMH press release, May 17, 2010, “Effectiveness of long-term use of antipsychoticmedication to treat childhood schizophrenia is limited.”
51. L. Sikich, “A pilot study of risperidone, olanzapine, and haloperidol in psychoticyouth,” Neuropsychopharmacology 29 (2004): 133–45.
52. Correll, “Antipsychotic use in children and adolescents.”
53. Also, C. Correll, “Assessing and maximizing the safety and tolerabilityof antipsychotics used in the treatment of children and adolescents,” J Clin Psychiatry 69. suppl. 4 (2008): 26–36.
54. I. Wonodi, “Tardive dyskinesia in children treated with atypical antipsychoticmedications,” Mov Disord 22 (2007): 1777–82.
55. P. Laita, “Antipsychotic-related abnormal involuntary movements andmetabolic and endocrine side effects in children and adolescents,” J Child AdolescPsychopharmacol 17 (2007): 487–502.
56. C. Arango, “Olanzapine compared to quetiapine in adolescents with a firstpsychotic episode,” Eur Child & Adolesc Psychiatry 18 (2009): 418–28.
57. G. Ratzoni, “Weight gain associated with olanzapine and risperidone in adolescentpatients,” J Am Acad Child Adolesc Psychiatry 41 (2002): 337–43.
58. C. Pangiotopoulos, “Increased prevalence of obesity and glucose intolerancein youth treated with second-generation antipsychotic medications,” Can JPsychiatry 54 (2009): 743–49
59. N. Patel. “Body mass indexes and lipid profiles in hospitalizedchildren and adolescents exposed to atypical antipsychotics,” J Child &Adolesc Psychopharmacol 17 (2007): 303–11.
60. Fraguas, “Efficacy and safety of second-generation antipsychotics”; De-Hert, “Metabolic and endocrine adverse effects.”
61. Panagiotopoulos, “First do no harm.”
62. Patel, “Body mass indexes and lipid profiles.”
63. Panagiotopoulos, “First do no harm.”
64. Vitiello, “Antipsychotics in children and adolescents.”
65. Laita, “Antipsychotic-related abnormal involuntary movements.”
66. See DeHert, “Metabolic and endocrine adverse effects”; Vitiello, “Antipsychoticsin children and adolescents”; Laita, “Antipsychotic-related abnormalinvoluntary movements”; Panagiotopoulos, “First do no harm”; and C. Correll,“Endocrine and metabolic adverse effects of psychotropic medications in childrenand adolescents,” J Acad Child Adolesc Psychiatry Am 45 (2006): 771–90.
67. De Hert, “Metabolic and endocrine adverse effects”; Panagiotopoulos,“First do no harm.”
68. R. McIntyre, “Metabolic and cardiovascular adverse events associated withantipsychotic treatment in children and adolescents,” Arch Pediatr Adolesc Med 162(2008): 929–35. Also see De Hert, “Metabolic and endocrine adverse effects”; Panagiotopoulos,“First do no harm.”
69. See Laita, “Antipsychotic-related abnormal involuntary movements”; DeHert, “Metabolic and endocrine adverse effects.”
70. Correll, “Antipsychotic use in children and adolescents.” Also see De Hert,“Metabolic and endocrine adverse effects.”
71. Findling, “Double-blind maintenance safety and effectiveness findings.”
72. L. Sikich, “Double-blind comparison of first-and second-generation antipsychotics.”Also see Correll, “Assessing and maximizing the safety and tolerabilityof antipsychotics”
73. J. Jerrell, “Neurological adverse events associated withantipsychotic treatment in children and adolescents,” J Child Neurol 23 (2008):1392–99.
74. Findling, “Double-blind maintenance safety and effectiveness findings.”
75. J. Jerrell, “Adverse events in children and adolescents treated with antipsychoticmedications,” Hum Psychopharmacol 23 (2008): 283–90.
76. J. Wade, “Tardive dyskinesia and cognitive impairment,” Biol Psychiatry 22(1987): 393–95.
77. M. Myslobodsky, “Central determinants of attention and mood disorder intardive dyskinesia,” Brain Cognition 23 (1993): 56–70.
78. B. Ho, “Progressive structural brain abnormalities and their relationship toclinical outcome,” Arch Gen Psychiatry 60 (2003): 585–94.
79. N, Andreasen, “Longitudinalchanges in neurocognition during the first decade of schizophrenia illness,”Int Cong Schiz Res (2005): 348.
80. K. Dorph-Petersen, “The infl uence of chronic exposure to antipsychoticmedications on brain size before and after tissue fixation,” Neuropsychopharmacology 3. (2005): 1649–61.
81. B. Ho, “Long-term antipsychotic treatment and brain volume,” Arch GenPsychiatry 68 (2011): 128–37.
82. M. Morgan, “Prospective analysis of premature mortality in schizophreniain relation to health service engagement,” Psychiatry Res 117 (2003): 127–35
83. S. Saha, “A systematic review of mortality in schizophrenia,” Arch Gen Psychiatry 6. (2007): 1123–31
84. M. Joukamaa, “Schizophrenia, neuroleptic medication, andmortality,” Br J Psychiatry 188 (2006): 122–27.
85. C. Colton, “Congruencies in increased mortality rates, years of potential lifelost, and causes of death among public mental health clients in eight states,” PrevChronic Dis 3 (April 2006).
86. McIntyre, D. A. (2010, May 19). Big pharma makes more money on kids,use of medications among the young rises. 247wallst.com, n.p. Retrieved fromhttp://247wallst.com/2010/05/19/big-pharma-makes-more-money-on-kids-useof-medications-among-the-young-rises/.
87. Kozel, M. (2011, February 5). Little pharma: The medication of U.S. children.Huffington Post.com, n.p. Retrieved from http://www.huffingtonpost.com/maggie-kozel-md/childrens-health-care_b_803167.html.
88. Olson, J. (2011, June 23). Bipolar label soars among kids. StarTribune, n.p.Retrieved from http://www.startribune.com/lifestyle/wellness/124136764.html.
89. Donaldson, L. (2010, May 3). Psychiatric drugging of American childrenis cause for alarm. Portland Press Herald, n.p. http://www.pressherald.com/opinion/psychiatric-drugging-of-american-children-is-cause-for-alarm_2010-05-03.html.
90. Olfson, M., Blanco, C., Liu, L., Moreno, C., Laje, G. (2006). National trendsin the outpatient treatment of children and adolescents with antipsychotic drugs.Archives of General Psychiatry, 63 (6), 679–685.
91. Szalavitz, M. (2011, May 26). Drugging the vulnerable: Atypical antipsychoticsin children and the elderly. Time, n.p. Retrieved from http://healthland.time.com/2011/05/26/why-children-and-the-elderly-are-so-drugged-up-on-antipsychotics/print
92. Kaplan, A. (2011, May 23). Nearly half of kids in inpatientpsychiatric program receive antipsychotics. Psychiatric Times, n.p. Retrieved from http://www.psychiatrictimes.com/conference-reports/apa2011/content/article/10168/1865851.
93. Llorente, M. D., Urrutia, V. (2006). Diabetes, psychiatry disorders, andthe metabolic effects of antipsychotic medications. Clinical Diabetes, 24 (1), 18–24.
94. Barnes, T.R.E., Braude, W. M. (1985). Akathisia variants and tardive dyskinesia.Archives of General Psychiatry, 42 (9), 874–878.
95. Ho, B. C., Andreason, N. C., Zieball, S., Pierson, R., Magnota, V. (2011).Long-term antipsychotic treatment and brain volume: A longitudinal study offirst-episode schizophrenia. Archives of General Psychiatry, 28 (2), 128–137.
96. Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatry drugs,and the astonishing rise of mental illness in America. New York: Crown Publishers.
97. Herper, M. (2004, Sept.). Antipsychotic prescribed as sleeping pill. Forbes.com, n.p. Retrieved from http://www.forbes.com/2004/09/08/cx_mh_0908seroquel.html.
98. Donaldson, Psychiatric drugging of American children.
99. Wilson, D. (2010, Sept. 1). Child’s ordeal shows risks of psychosis drugsfor the young. New York Times, n.p. Retrieved from http://www.nytimes.com/2010/09/02/business/02kids.html?pagewanted=all.
100. Olson, Bipolar label soars among kids.
101. Donaldson, Psychiatric drugging of American children.
102. Rushton, J. L., Clark, S. J., Freed, G. L. (2000). Pediatrician and family physicianprescription of selective serotonin reuptake inhibitors. Pediatrics, 105 (6), e82.
103. AAP Department of Community and Specialty Pediatrics. (2010, July). Resourceshelp primary care clinicians address mental health concerns. AAP News, 3. (7), 34.
104. Kim, W. J. (2003). Child and adolescent psychiatry workforce: A criticalshortage and national challenge. Academic Psychiatry, 27, 277–282.
105. Donaldson, Psychiatric drugging of American children.
106. Laforgia, M. (2011, May 24). Huge doses of potent antipsychotics fl ow intostate jails for troubled kids. Palm Beach Post, n.p. http://www.psychsearch.net/psych_news/?p=1697.
107. Zito, J. M., Safer, D. J., Sai, D., Gardener, J. F., Thomas, D., Coombes, P.,… Mendez-Lewis, M. (2008). Psychotropic medication patterns among youthin foster care. Pediatrics, 121 (1), e157–163.
108. Kaplan, Nearly half of kids in inpatient psychiatric program receiveantipsychotics.
109. Donaldson, Psychiatric drugging of American children.
110. Whitaker, R. (2002). Mad in America: Bad science, bad medicine, and the enduringmistreatment of the mentally ill. New York: Basic Books.
111. Charland, L. C. (2007). Benevolent theory: Moral treatment at the York retreat.History of Psychiatry, 18 (1), 61–80.
112. Whitaker, Mad in America, p. 27.
113. Whitaker, Mad in America ; Dowbiggin, I. R. (1997). Keeping America sane: Psychiatryand eugenics in the United States and Canada 1880–1940. Ithaca, NY: CornellUniversity Press
114. Black, E. (2003). War against the weak: Eugenics and America’s campaignto create a master race. New York: Four Walls Eight Windows.
115. Whitaker, Mad in America.
116. Illich, I. (2000). Limits to medicine: Medical nemesis, the expropriation of health.London: Marion Boyars Press.
117. Whitaker, Mad in America.
118. Dowbiggin, Keeping America sane.
119. Malthus, T. (2008/1798). An essay on the principle of population. Oxford: OxfordUniversity Press.
120. Galton, F. (2004). Essays in eugenics. Honolulu, HI: University Press of thePacific.
121. Chung, M. C., Nolan, P. (1998). Children and challenging behaviour: Pastand present in the United Kingdom. Children and Society, 12, 251–262.
122. Chung & Nolan, Children and challenging behaviour, p. 252.
123. Whitaker, Mad in America, p. 52.
124. Kiesler, D. (2000). Beyond the disease model of mental disorders. Santa Barbara,CA: Praeger.
125. Felder, A. J., Robbins, B. D. (2011). A cultural-existential approach to therapy:Merleau-Ponty’s phenomenology of embodiment and its implications forpractice. Theory and Psychology, 21 (3).
126. Pescosolido, B. A., Martin, J. K., Long, S., Medina, T. R., Phelan, J. C., &Link, B. G. (2010). “A disease like any other”? A decade of change in public reactionsto schizophrenia, depression, and alcohol dependence. American Journal ofPsychiatry, 167, 1321–1330.
127. Elkins, D. N. (2009). Humanistic psychology: A clinical manifesto. ColoradoSprings, CO: University of the Rockies Press
128. Mosher, L. R., Hendrix, V. (2004).Soteria: Through madness to deliverance. Bloomington, IN: Xlibris; Duncan, B. L.
129. Miller, S. D., Wampold, B. E., Hubble, M. A. (Eds.). (2009). The heart and soul ofchange: Delivering what works in therapy (2nd. Washington, DC: American PsychologicalAssociation.
130. Hellerman, C. (2011, July 22). Cocaine: The evolution of the once “wonder”drug. CNN, n.p. Retrieved from http://www.koco.com/r/28638691/detail.html.
131. El-Hai, J. (2005). The lobotomist: A maverick genius and his tragic quest to rid theworld of mental illness. New York: Wiley.
132. LeDoux, J. (1996). The emotional brain. In J. M. Jenkins, K. Oatley, & N. L.Stein (Eds.), Human emotions: A reader (pp. 98–111). Malden, MA: Blackwell.
133. Whitaker, Mad in America.
134. Hunt, M. (1994). The story of psychology. Norwell, MA: Anchor.
135. Oh, V.M.S. (1994). The placebo effect: Can we use it better? British MedicalJournal, 309, 69
136. Shapiro, A. K. (1964). A historic and heuristic definition of the placebo.Psychiatry, 27, 52–80.
137. Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L.,… Lembo, A. J. (2005). The placebo effect in irritable bowel syndrome trials: Ameta-analysis. Neurograstroenterology & Motility, 17 (3), 332–340.
138. Kirsch, I. (2010). The emperor’s new drugs: Exploding the antidepressant myth.New York: Basic Books.
139. Fournier, J., DeRubeis, R., Hollon, S., Dimidjian, S., Amsterdam, J., Shelton, R., Fawcett, J. (2010). Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA, 303 (1), 47–53.
140. Kirsch, The emperor’s new drugs.
141. Angell, M. (2011, June 23). The epidemic of mental illness: Why? New YorkReview of Books, n.p.
142. Angell, M. (2011, July 11). The illusions of psychiatry. NewYork Review of Books, n.p. Retrieved from
143. Kirsch, The emperor’s new drugs ; Whitaker, Anatomy of an epidemic
144. Carlat, D. (2010). Unhinged: The trouble with psychiatry—a doctor’s revelations about a professionin crisis. New York: Free Press.
145. Faille, C. (2011, July 12). Investing for a backlash against psychopharmacology.Forbes.
146. Whitaker, Anatomy of an epidemic,.
147. Robbins, B. D., Higgins, M., Fisher, M., Over, K. (2011). Conflicts of interestin research on antipsychotic treatment of pediatric bipolar disorder, temperdysregulation disorder, and attenuated psychotic symptoms syndrome: Exploringthe unholy alliance between big pharma and psychiatry. Journal of Psychological Issuesin Organizational Culture, 1 (4), 32–49.
148. Cosgrove, L., Krimsky, S., Vijayaraghavan, M., Schneider, L. (2006). Financialties between DSM-IV panel members and the pharmaceutical industry.Psychotherapy and Psychosomatics, 75, 154–160.
149. Cosgrove, L. (2010, April). Re-thinking the meaning of “evidence-based medicine”in an industry dominated climate. Keynote address at the UndergraduateHumanities and Human Sciences Conference, Point Park University, Pittsburgh,PA.
150. American Psychiatric Association. (2010a). DSM-5 development: Temperdysregulation disorder with dysphoria. Retrieved from http://www.dsmt.org
151. American Psychiatric Association. (2010b). Justification for temper dysregulationwith dysphoria. Retrieved from http://www.dsm5.org
152. American PsychiatricAssociation. (2010c). Attention psychotic symptoms syndrome. Retrieved fromhttp://www.dsm5.org
153. Frances, A. (2010a). DSM-5 temper dysregulation—good intentions, badsolution. Psychology Today, n.p.
154. Rusch, N., Corrigan, P. W., Todd, A. R., Bodenhausen, G. V. (2010). Implicitself-stigma in people with mental illness. Journal of Nervous Mental Disease, 198. 150–153.
155. Frances, A. (2010b). DSM-5 “psychosis risk syndrome”—far too risky. PsychologyToday, n.p.
156. Felder and Robbins, A cultural-existential approach to therapy.
157. U.S. Census Bureau. (2002b). Statistical abstract of the United States (123rded.). Washington, DC: U.S.
158. Berk, L. E. (2005). Why parenting matters. In Olfman, S. (Ed.) Childhood lost(pp. 19–53). Westport, CT: Praeger.
159. Olfman, S. (Ed.). (2005). Childhood lost. Westport, CT: Praeger.
160. Cavoukian, R., Olfman, S. (Eds.). (2006). Child honoring: How to turn thisworld around. Westport, CT: Praeger.
161. Bronfenbrenner, U. (1988). Strengthening family systems. In E. F. Zigler &M. Frank (Eds.), The parental leave crisis: Toward a national policy (pp. 143–160). NewHaven, CT: Yale University Press.
162. Schore, A. (2003). Affect dysregulation and disorders of the self. New York: Norton.
163. Karen, R. (1998). Becoming attached: First relationships and how they shape ourcapacity to love. New York: Oxford University Press.
164. Small, M. (2004). The natural history of children. In S. Olfman (Ed.), Childhoodlost: How American culture is failing our kids (pp. 3–18). Westport, CT: Praeger. 10.
165. Karen, Becoming attached, p. 3. Small, The natural history of children.
166. Stern, D. (1985). The interpersonal world of the infant. New York: Basic Books.
167. Rice, R. S. (1997). Neurophysiological development in prematureinfants following stimulation. Developmental Psychology, 13, 69–76
168. White, J. L., &Labarba, R. C. (1976). The effects of tactile and kinesthetic stimulation onneonatal development in the premature infant. Developmental Psychobiology, 9. 569–77.
169. McKenna, J. J., Mosko, S. S., Richard, C., Drummond, S., Hunt, L., Cetel, M. B. & Arpaia, J. (1994). Experimental studies of infant-parent co-sleeping: Mutualphysiological and behavioral infl uences and their relevance to SIDS (suddeninfant death syndrome). Early Human Development, 38, 187–201.
170. Angier, N. (1994, May 24). Mother’s milk found to be potent cocktail of hormones.New York Times, p. B5.
171. Gerehardt, S. (2004). Why love matters: How affection shapes a baby’s brain.New York: Brunner-Routledge.
172. Schore, Affect dysregulation and disorders of the self.
173. Gerehardt, Why love matters.
174. Baumrind, D. (1971). Current patterns of parental authority. DevelopmentalPsychology Monograph, 4 (1, Pt. 2)
175. Kuczynski, L. & Lollis, S. (2002). Four foundationsfor a dynamic model of parenting. In J.R.M. Gerris (Ed.), Dynamics of parenting.Hillsdale, NJ: Erlbaum
176. Russell, A., Mize J., Bissaker K. (2002). Parent-childrelationships. In P. K. Smith & C. Hart (Eds.), Handbook of childhood social development.Oxford, UK: Blackwell.
177. Berk, L. E. (2005). Infants, children and adolescents. Boston: Pearson & Allynand Bacon.
178. Erikson, E. H. (1950). Childhood and society. New York: Norton.
179. Harlow, H. F., Zimmerman, R. (1959). Affectional responses in the infantmonkey. Science, 130, 421–432
180. Small, M. F. (1999). Our babies, ourselves: How biologyand culture shape the way we parent. New York: Anchor Books.
181. Bronfenbrenner, U. (1988). Strengthening family systems. In E. F. Zigler &M. Frank (Eds.), The parental leave crisis: Toward a national policy (pp. 143–160). NewHaven, CT: Yale University Press.
182. Bronfenbrenner, U. (1992). Child care in the Anglo-Saxon mode. In M. E. Lamb, J. J. Sternberg, C. P. Hwang & A. G. Broberg (Eds.), Child care in context (pp.281–291). Hillsdale, NJ: Lawrence Erlbaum.
183. Bronfenbrenner, U. (1985). The future of childhood. In V. Greaney (Ed.),Children: Needs and rights (pp. 167–186). New York: Irvington Publishers.
184. John Breeding, PhD, and Amy Philo, “Relentless and Tragic Marketing:Psychiatric Drugs from Before the Cradle to the Grave,” Unite for Life, Nov. 8, 2010,http://uniteforlife.wordpress.com/2010/11/08/relentless-and-tragic-marketingpsychiatric-drugs-from-before-the-cradle-to-the-grave-by-john-breeding-phdand-amy-philo/.
185. Robert Whitaker, Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs,and the Astonishing Rise of Mental Illness in America (New York: Crown Publishers,2010), 3.
186. Bill Bekrot, “Prescription Drug Use by US Children on the Rise,” Reuters,May 19, 2010, http://www.reuters.com/article/2010/05/19/medco-childrenidUSN1924289520100519.
187. Dr. Joseph Mercola, “Selling Fear and Sickness,” Mercola, Sept. 29, 2005,http://articles.mercola.com/sites/articles/archive/2005/09/29/selling-fear-andsickness.aspx.
188. Breeding and Philo, “Relentless and Tragic Marketing.”
189. Whitaker, Anatomy of an Epidemic, 318.
190. “Joseph Biederman,” Wikipedia the Free Encyclopedia, Wikimedia FoundationInc., Jan. 2, 2011, http://en.wikipedia.org/wiki/Joseph_Biederman.
191. Carey Goldberg, “Papers Reveal Push on Drug Firm Funds,” Boston Globe, Nov. 25. 2008, http://www.boston.com/news/local/massachusetts/articles/2008/11/25/papers_reveal_push_on_drug_firm_funds/.
192. Jed Lipinski, “ ‘Anatomy of an Epidemic’: The Hidden Damage of PsychiatricDrugs,” Salon, April 27, 2010, http://www.salon.com/books/feature/2010/04/27/interview_whitaker_anatomy_of_an_epidemic.
193. Terry Messman, “Psychiatric Drugs: Chemical Warfare on Humans—Interview with Robert Whitaker,” Natural News, Aug. 27, 2005, http://www.naturalnews.com/011353.html#ixzz1DSN8c6zN.
194. Stephanie Saul, “Merck Wrote Drug Studies for Doctors,” New York Times,April 16, 2008, http://www.nytimes.com/2008/04/16/business/16vioxx.html.
195. John Dorschner, “UM Professor Accused of Submitting Ghostwritten Textbook,”Miami Herald, Dec. 3, 2010, http://www.miamiherald.com/2010/12/03/1954823/um-professor-accused-of-submitting.html.
196. Marc A. Rodwin, “Drug Advertising, Continuing Medical Education, andPhysician Prescribing Review: A Historical Review and Reform Proposal,” Conundrumsand Controversies in Mental Illness (Winter 2010), http://www.law.suffolk.edu/faculty/addinfo/rodwin/DrugAdsCME+MDprescribingReformProposal.pdf.
197. Vera Hassner Sharav, “BMJ & Lancet Wedded to Merck CME Partnership,”Alliance for Human Research Protection, Feb. 14, 2011, http://www.ahrp.org/cms/content/view/766/55/.
198. Adriane Fugh-Berman and Shahram Ahari, “Following the Script: HowDrug Reps Make Friends and Infl uence Doctors,” PLoS Medicine 4 (2007), http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040150.
199. “New Jersey Youth Get Rapid Access to Mental Health Services,” Bristol-Myers Squibb, Dec. 12, 2008, http://investor.bms.com/phoenix.zhtml?c=106664&p=irol-newsArticle_Print&ID=1235521&highlight=.
200. “National Alliance on Mental Illness,” Wikipedia the Free Encyclopedia, WikimediaFoundation Inc., 2008, http://en.wikipedia.org/wiki/National_Alliance:for_the_Mentally_Ill.
201. Gardiner Harris, “Drug Makers Are Advocacy Group’s Biggest Donors,”New York Times, Oct. 21, 2009, http://www.nytimes.com/2009/10/22/health/22nami.html.
202. Dr. Joseph Mercola, “Drug Companies Triple Money on Direct-to-ConsumerDrug Ads,” Mercola, Feb. 27, 2002, http://articles.mercola.com/sites/articles/archive/2002/02/27/drug-ads-part-two.aspx.
203. Robert Whitaker, “Summing Up the NIMH Trials: Evidence of an EffectiveParadigm of Care?” Mad in America, May 28, 2010, http://www.psychologytoday.com/blog/mad-in-america/201005/summing-the-nimhtrials-evidence-effective-paradigm-care.
204. M. Asif Ishmail, “Drug Lobby Second to None: How the Pharmaceutical IndustryGets Its Way in Washington,” The Center for Public Integrity, July 7, 2005,http://projects.publicintegrity.org/rx/report.aspx?aid=723.
205. Bara Vaida and Christopher Weaver, “Drug Lobby’s Tax Filings RevealHealth Debate,” Kaiser Health News, Dec. 1, 2010, http://www.kaiserhealthnews.org/Stories/2010/December/01/phrma-drug-lobbying-health-reform.aspx.
206. Kathleen Blanchard, “Pharma Spends 40 Million on Lobbying,” Emax-Health, July 24, 2004, http://www.emaxhealth.com/1020/10/32434/pharmaspends-40-million-lobbying.html.
207. Emad Mekay, “What 800 Million Buys on Capitol Hill,” Common Dreams,July 8, 2005, http://www.commondreams.org/headlines05/0708–03.htm.
208. Ed Silverman, “Bart Stupack: From Pharma Watchdog to Lobbyist,” Pharmalot,Apr. 11, 2011, http://www.pharmalot.com/2011/04/bart-stupak-frompharma-watchdog-to-lobbyist/.
209. Gregory M. Lamb, “A New Corporate Villain—Drugmakers?” ChristianScience Monitor, Sept. 20, 2004, http://www.csmonitor.com/2004/0920/p11s02-ussc.html.
210. Vera Hassner Sharav, “Children Rx ADHD Drugs 7.4 Times Increased Riskof Sudden Death,” Alliance for Human Research Protection, Jun. 17, 2009, http://www.ahrp.org/cms/content/view/609/52/.
211. Thomas Sullivan, “Prescription Drug Sakes 2009—IMS Data,” Policy andMedicine, Apr. 7, 2010, http://www.policymed.com/2010/04/prescription-drugsales-2009—-ims-data.html.
212. Ed Silverman, “Evidence for Abilify & Bipolar Disorder Is Debated,” Pharmalot,May 4, 2011, http://www.pharmalot.com/2011/05/evidence-for-abilifybipolar-disorder-is-debated/.
213. Jim Edwards, “1,000 a Pop: How Forest Labs Bribed Doctors to PrescribeAntidepressants to Kids,” BNET, Sept. 15, 2010, http://www.bnet.com/blog/drug-business/1000-a-pop-how-forest-labs-bribed-doctors-to-prescribe-antidepressants-to-kids/5753.
214. Duff Wilson, “Side Effects May Include Lawsuits,” New York Times, Oct. 2, 2010. http://www.nytimes.com/2010/10/03/business/03psych.html.
215. Patricia Wen, “Some in Congress Look at Incentives in Disability Benefit,” Boston Globe, Jan. 18, 2011, http://www.boston.com/news/local/massachusetts/articles/2011/01/18/some_in_congress_look_at_incentives_in_disability_benefit/?s_campaign=8315.
216. John Kelly “Psyche Meds in Jails,” Youth Today, Oct. 1, 2010, http://youthtoday.org/view_article.cfm?article_id=4344.
217. Evelyn Pringle, “Suicide Prevention Drug Pushing Racket—Part II,” NaturalNews, Aug. 21, 2009, http://www.naturalnews.com/026895_suicide_drugs_suicides.html.
218. Vince Boehm, “The Dark Underbelly of Antipsychotics,” Beyond Meds, May 22, 2010. http://bipolarblast.wordpress.com/2010/05/22/the-dark-underbelly-of%c2%a0antipsychotics/.
219. Cooper, W. O., Arbogast, P. G., Ding, H., Hisckson, G. B., Fuchs, C., Ray, W. A. (2006). Trends in prescribing of antipsychotic medications for U.S. children.Ambulatory Pediatrics, 6 (2), 79–83
220. Crystal, S., Olfson, M., Huang, C., Pincus, H., &Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness,and policy challenges. Health Affairs, 28, 770–781
221. Olfson, M., Blanco, C., Liu, L.,Moreno, C., Laje, G. (2006). National trends in outpatient treatment of childrenand adolescents with antipsychotic drugs. Archives of General Psychiatry, 63 (6), 679–685.
222. Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A., Olfson, M. (2007).National trends in the outpatient diagnosis and treatment of bipolar disorder inyouth. Archives of General Psychiatry, 64, 1032–1039
223. Patel, N. C., Crismon, M. L.,Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., Jensen, P. S. (2005).Trends in the use of typical and atypical antipsychotics in children and adolescents.Journal of the American Academy of Child and Adolescent Psychiatry, 44 (6), 548–556
224. Olfson, M., Crystal, S., Huang, C., Gerhard, T. (2010). Trends in antipsychoticdrug use by very young, privately insured children. Journal of the American Academyof Child Psychiatry, 49, 13–23.
225. Cooper, W. O., Arbogast, P. G., Ding, H., Hisckson, G. B., Fuchs, C., Ray, W. A. (2006). Trends in prescribing of antipsychotic medications for U.S. children.Ambulatory Pediatrics, 6 (2), 79–83
226. Pathak, P., West, D., Martin, B., Helm, & Henderson, C. (2010). Evidence-based use of second-generation antipsychotics in a stateMedicaid pediatric population, 2001–2005. Psychiatric Service, 61, 123–129.
227. dosReis, S., Zito, J. M., Safer, D. J., Gardner, J. F., Puccia, K. B., &Owens, P. L. (2005). Multiple psychotropic medication for youths: A two-state comparison.Journal of Child & Adolescent Psychopharmacology, 15 (1), 68–77.
228. Kelly, J. (2010, October 1). Psych meds in jails. Youth Today. Retrieved fromhttp://youthtoday.org/view_article.cfm?article_id=4344
229. Norcross, J. C., Beutler, L. E., Levant, R. F. (2006). Prologue. In J. C. Norcross, L. E. Beutler & R. L. Levant (Eds.), Evidence-based practices in mental health:Debate and dialogue on the Fundamental Questions (pp. 3–12). Washington, DC: AmericanPsychological Association
230. Benjamin, L. T., Baker, D. B. (Eds.). (2000). Historyof psychology: The Boulder Conference. American Psychologist, 55, 233–254.
231. APA Working Group on Psychoactive Medications for Children and Adolescents.(2006). Report of the Working Group on Psychoactive Medications for Childrenand Adolescents. Psychopharmacological, psychosocial, and combined interventions forchildhood disorders: Evidence base, contextual factors, and future directions. Washington,DC: American Psychological Association.
232. Kowatch, R. A., Fristad, M. A., Birmaher, B., Wagner, K. D., Findling, R. L.,Hellander, M., Child Psychiatric Workgroup on Bipolar Disorder. (2005). Treatmentguidelines for children and adolescents with bipolar disorder. Journal of theAmerican Academy of Child & Adolescent Psychiatry, 44 (3), 213–235.
233. Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., Malhotra,K. A. (2009). Cardiometabolic risk of second-generation medications duringfirst-time use in children and adolescents. JAMA, 302 (16), 1765–2322.
234. Wilson, D. (2009, October 28). Rapid weight gain associated linked to antipsychoticdrugs. New York Times, p. B.1.
235. Varley, C. K., McClellan, J. (2009). Implications of marked weight gainassociated with atypical antipsychotic medications in children and adolescents.JAMA, 302 (16), 1811–1812.
236. Woods, S. W., Morgenstern, H., Saksa, J. R., Walsh, B. C., Sullivan, M. C.,Money, R.,… Glazer, W. M. (2010). Incidence of tardive dyskinesia with atypicalversus conventional antipsychotic medications: A prospective cohort study. TheJournal of Clinical Psychiatry, 71 (4), 463–474.
237. http://www.medscape.com/viewarticle/717316?src=emailthis
238. Sparks, J., Duncan, B. L., Cohen, D., Antonuccio, D. (2010). Psychiatricdrugs and common factors: An evaluation of risks and benefits for clinical practice.In B. L. Duncan, S. D. Miller, B. E. Wampold & M. A. Hubble (Eds.), The heartand soul of change: Delivering what works (2nd, pp. 199–236). Washington, DC:American Psychological Association.
239. Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L.,et al. (2008). Double-blind comparison of first-and second-generation antipsychoticsin early-onset schizophrenia and schizoaffective disorder: Findings from thetreatment of early-onset schizophrenia spectrum disorders (TEOSS) study. AmericanJournal of Psychiatry, 165, 1420–1431
240. Findling, R., Johnson, J., McClellan, J., Frazier, J., Vitiello, B., Hamer, R., et al. (2010). Double-blind maintenance safety andeffectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum(TEOSS) study. Journal of the American Academy of Child Adolescent Psychiatry, 49,583–594.
241. Findling, R., Robb, A., Nyila, M., Forbes, R. A., Jin, N., Ivanova, S., et al.(2008). A multiple-center, randomized, double-blind, placebo-controlled study oforal aripiprazole for treatment of adolescents with schizophrenia. American Journalof Psychiatry, 165 (11), 1432–1441.
242. Wilson, D. (2010, September 2). Child’s ordeal reveals risks of psychiatricdrugs in young. New York Times, p. A.1.
243. Lyotard, J. (1979). The postmodern condition: A report on knowledge. Minneapolis:University of Minnesota Press.
244. Duncan, B., Miller, S., Sparks, J. (2004). The heroic client: A revolutionaryway to improve effectiveness through client-directed, outcome-informed therapy. SanFrancisco: Jossey-Bass
245. Sparks, J. A., Duncan, B. L. & Murphy, J. J. (2007). Medication,children, & schools. In J. J. Murphy & B. L. Duncan (authors), Brief outcome informedintervention in the schools. New York: The Guilford Press.
246. IMS Health. (2010). IMS Health reports U.S. sales grew 5.1 percent in 2009,to 300.3 billion. Retrieved from http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=d690a27e9d5b7210VgnVCM100000ed152ca2RCRD
247. Weber, T., Ornstein, C. (2010, November 1). Dollars for docs: Who’son pharma’s top-paid list? Retrieved from http://www.propublica.org/article/profiles-of-the-top-earners-in-dollar-for-docs
248. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a giftever just a gift? JAMA, 283 (3), 373–380.
249. Angell, M. (2000). Is academic medicine for sale? New England Journal ofMedicine, 341 (20), 1516–1518.
250. Horton, R. (2004). The dawn of McScience. New York Review of Books 51 (4): 7–9.
251. Wilson, D. (2010, November 29). Drug maker wrote book under 2 doctors’names, documents say. New York Times, p. B.3.
252. Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., Leucht, S. (2006).Why olanzapine beats risperidone, risperidone beats quetiapine, and comparisonstudies of second-generation antipsychotics. American Journal of Psychiatry, 163 (2),185–194.
253. Vedantam, S. (2006, April 12). Comparison of schizophrenia drugs often favorsfirm funding study. The Washington Post, p. A01.
254. Bekelman, J. E., Li, Y., Gross, C. P. (2003). Scope and impact of financialconfl icts of interest in biomedical research: A systematic review. JAMA, 289 (4),454–465.
255. Melander, H., Ahlqvist-Rastad, J., Meijer, G., Beermann, B. (2003). Evidenceb(i)ased medicine—selective reporting from studies sponsored by pharmaceuticalindustry: review of studies in new drug applications. British Medical Journal, 326 (7400),1171–1173
256. Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparentefficacy. New England Journal of Medicine, 358, 252–260
257. Wieseler, B., McGaura, N., &Kaiser, T. (2010). Finding studies on reboxetine: A tale of hide and seek. British MedicalJournal, 341, c4942.
258. Angell, M. (2009). Drug companies and doctors: A story of corruption.New York Review of Books. Retrieved from http://www.nybooks.com/articles/archives/2009/jan/15/drug-companies-doctorsa-story-of-corruption/?page=1
259. Whitaker, R. (2010). Anatomy of and epidemic: Magic bullet, psychiatric drugs, andthe astonishing rise of mental illness in America. New York: Crown Publishers, p. 326.
260. Harris, G. (2008, November 19). Use of antipsychotics in children is criticized.New York Times, p. A.20.
261. Harris, G. (2008, November 25). Ties between child psychiatry center drugmaker. New York Times, p. A.22.
262. Kowalczyk, L. (2009, March 21). Senator broadens inquiry into psychiatrist.Boston Globe, p. B.1, Metro.
263. http://www.medscape.com/viewarticle/727430
264. Of note, not only were Findling and the second author, Robb, listed as receivingresearch support from, acting as consultant to, and/or serving on a speakersbureau for Bristol-Myers Squibb/Otsuka, the manufacturer of Abilify, but theremaining nine authors were listed as employees of that company, p. 1432.
265. Willman, D. (2003, December 7). Stealth merger: Drug companies and governmentmedical research. Los Angeles Times, p. A.1
266. Willman, D. (2005, July 14).NIH inquiry shows widespread ethical lapses, lawmaker says. Los Angeles Times,p. A.23.
267. Lurie, P., Almeida, C. M., Stine, N., Stine, A., Wolfe, (2006). Financial conflict of interest disclosure and voting patterns at Food and Drug AdministrationDrug Advisory Committee meetings. Journal of the American Medical Association, 29. (16), 26, 1921–1928.
268. Cosgrove, L., Krimsky, S., Vijayaraghavan, M., Schneider, L. (2006). Financialties between DSM-IV panel members and the pharmaceutical industry.Psychotherapy Psychosomatics, 75, 154–160.
269. Choudhry, N. K., Stelfox, H. T., Detsky, A. S. (2002). Relationships betweenauthors of clinical practice guidelines and the pharmaceutical industry.JAMA, 287 (5), 612–617.
270. Hughes, C. W., Emslie, G. J., Crismon, M. L., Posner, K., Birmaher, B.,Ryan, N., et al. (2007). Texas Children’s Medication Algorithm Project: Updatefrom Texas Consensus Conference Panel on Medication Treatment for childhoodmajor depressive disorder. Journal of the American Academy of Child & AdolescentPsychiatry, 46 (6), 667–686.
271. Antonuccio, D. O., Danton, W. G., McClanahan, T. M. (2003). Psychologyin the prescription era: Building a firewall between marketing and science. A mericanPsychologist, 58 (12), 1028–1043.
272. McClellan, J., Kowatch, R., Findling, R. L. & Workgroup on Quality Issues.(2007). Practice parameters for the assessment and treatment of children andadolescents with bipolar disorder. Journal of the American Academy of Child & AdolescentPsychiatry, 46 (1), 107–125.
273. AAMFT consumer update: Mental illness in children. Retrieved from http://www.aamft.org/families/Consumer_Updates/MentalIllnessinChildren.asp
274. AAMFT consumer update: Bipolar disorder in children and adolescents.Retrieved from http://www.aamft.org/families/Consumer_Updates/BipolarDisorderinChildrenandAdolescents.asp
275. Nonmedical practitioners can also advocate for ethical practice guidelinesfor prescribers, as recommended by Duncan and Antonuccio (2010): (1) full disclosureof risks, (2) psychosocial options tried first, (3) no nonempirically supportedpractices, (4) privileging patient-rated measures in practice and research, (5) nopharmaceutical perks, and (6) the creation of an unbiased database to inform practitionersand clients. (Duncan, B., Antonuccio, D. (2010). A patient bill of rights forpsychotropic prescription: A call for a higher standard of care. Manuscript submitted forpublication.)
276. Duncan, B. L. (2010). On becoming a better therapist. Washington, DC: AmericanPsychological Association.
277. Gottstein, J. (2010). Ethical and moral obligations arising from revelationsof pharmaceutical company dissembling.” Ethical Human Psychology and Psychiatry 1. (1), 22–29.
278. Nowak, M. (2008). Interim report of the Special Rapporteur on torture and othercruel, inhuman or degrading treatment or punishment. United Nations General Assembly, 16. (“The Special Rapporteur notes that forced and non-consensual administrationof psychiatric drugs, and in particular of neuroleptics, for the treatment of amental condition needs to be closely scrutinized. Depending on the circumstancesof the case, the suffering infl icted and the effects upon the individual’s health mayconstitute a form of torture or ill-treatment.”)
279. American Psychological Association. (2006). Resolution against torture andother cruel, inhuman, and degrading treatment or punishment ; American PsychologicalAssociation. (2007). Reaffirmation of the American Psychological Association positionagainst torture and other cruel, inhuman, or degrading treatment or punishment andits application to individuals defined in the United States Code as “enemy combatants.”
280. N.C. App. 680.687 (NC App. 1980), overruled on other grounds. See, also,Indiana Code § 25–22–5-1–2(a)(18); Columbia Physical Therapy, Inc., P.S., v. BentonFranklin Orthopedic Associates, 228 P.3d 1260, 1266 (Washington 2010).
281. National Association of Social Workers. (2008). Code of ethics of the NationalAssociation of Social Workers, National Association of Social Workers, 1996, revised 2008.
282. http://criticalthinkrx.org
283. DeShaney v. Winnebago County Dep’t of Soc. Servs., 489 U.S. 189, 199–200 (1989).
284. See, American Academy of Pediatrics v. Lungren, 940 P.2d 797, 814–16, 819(1997); In re T.W., 551 So.2d 1186, 1194 (Fla.1989); Planned Parenthood of Central N.J.v. Farmer, 165 N.J. 609, 762 A.2d 620, 626, 631–39 (2000); State v. Planned Parenthoodof Alaska, 35 P.3d 30, 41 (Alaska 2001).
285. Camp, A. (2011). A mistreated epidemic: State and federal failure to adequatelyregulate psychotropic medications prescribed to children in foster care. 8. Temple L. Rev. 101.
286. Dawsey, D. (2011, March 28). Was a Detroit mother right to resist efforts byChild Protective Services, police to take her child? MLive.com.
287. Burton, A. (2010). “They use it like candy”: How the prescription of psychotropicdrugs to state-involved children violates international law. 35 Brooklyn Journalof International Law 453.
288. Doek, J. E. (2006). What does the Children’s Convention require? 20 EmoryInternational Law Rev. 199.
289. Stahl, R. M. (2007). “Don’t forget about me”: Implementing Article 12 of theUnited Nations Convention on the Rights of the Child. 24 Ariz. J. Int’l & Comp. L. 803.
290. Law Project for Psychiatric Rights, Inc. v. State of Alaska et al., Case No. 3AN08–10115CI, Superior Court, Third Judicial District, State of Alaska.
291. The Amended Complaint is available at http://psychrights.org/States/Alaska/PsychRightsvAlaska/PsychRightsvAlaskaKidDruggingComplaintAmended.pdf
292. Crystal, S., Olfson, M., Huang, C., Pincus, H., Gerhard, T. (2009). Broadeneduse of atypical antipsychotics: Safety, effectiveness, and policy challenges.Health Affairs, 28, 770–781; “Are foster kids overmedicated?” Need to Know, PBS,Texas, Jan. 7, 2011.
293. Heckler v. Community Health Services, 467 U.S. 51, 63–64 (1984).
294. United States v. Nazon, 940 F.2d 255, 259 (7th Cir. 1991); U.S. v. CooperativeGrain & Supply, 476 F.2d 47, 55–60 (8th Cir. 1973)
295. Kesselheim, A., et al. (2011). Strategies and practices in off-label marketingof pharmaceuticals: A retrospective analysis of whistleblower complaints. PLOSMedicine
296. The Model Complaint is available at http://psychrights.org/Education/ModelQuiTam/PsychRightsModelQuiTamComplaint.pdf
297. Page 21 in Docket No. 163, United States ex rel Law Project for PsychiatricRights v. Matsutani et al., No. 3:09-cv-80, and Docket No. 26 in U.S. ex rel Griffin v.Martino, Family Centered Services and Safeway, No. 3:09-cv-246, available at http://psychrights.org/States/Alaska/Matsutani/163–100924Order2DismissMatsutani.pdf
298. Whitaker, R. (2010). Anatomy of an epidemic. New York: Crown.
299. Lieberman, A. F., Van Horn, P. (2008). Psychotherapy with infants and youngchildren. New York: Guilford Press.
300. Bowlby, J. (1969, 1975, 1980). Attachment and loss (3 vols.). New York: BasicBooks.
301. Fraiberg, S. (1980). Clinical studies in infant mental health. New York: BasicBooks.
302. Schore, A. N. (1994). Affect regulation and the origin of the self. New Jersey:Lawrence Erlbaum.
303. Siegel, D. J. (1999). The developing mind. New York: Guilford Press
304. Siegel, D. J. (2004). Parenting from the inside out. New York:. Tarcher/Penguin
305. Siegel, D. J., Fosha, D., Solomon, M. F. (2009). The healing power of emotion. NewYork: W.W. Norton
306. Perry, B. D., Szalavitz, M. (2006). The boy who was raised as adog. New York: Basic Books
307. Perry, B. D., Szalavitz, M. (2010). Born for love. NewYork: HarperCollins
308. Stern, D. N. (1985). The interpersonal world of the infant. NewYork: Basic Books.
309. Coles, R. (1989). The call of stories. Boston: Houghton Miffl in Company.
310. The title “The Unfinished Copernican Revolution” is taken from a paper bythat name written by the French psychoanalyst Jean Laplance (1999).
311. Lewis, M., Brown, T. E., Hooven, M., O’Hare, E. (1978, Spring). Medicationin residential treatment. Child Psychiatry and Human Development, 8 (3).
312. Olfman, S. (Ed.). (2007). Bipolar children. Westport, CT: Praeger Publishers.
313. Sprinson, J. S. & Berrick, K. (2009). Relationship-based, behavioral interventionwith vulnerable children and families. New York: Oxford University.
314. Duncan, et al., The Heart & Soul of Change.
315. Moynihan and Cassells, Selling Sickness.
316. Pelham (2009) in Midkiff and Wyatt, “Has Behavioral Science Tumbledthrough the Looking Glass?”
317. Wikipedia, http://en.wikipedia.org/wiki/Arnold_van_Gennep.
318. Van Gennep, The Rites of Passage.
319. Wiener, N. (1948) Cybernetics: Or Control and Communication in the Animaland the Machine. Cambridge. MA, MIT Press.
320. V. Turner, (1969) The Ritual Process: Structure and Anti-Structure. 1995 paperbackAldine Transaction.
321. V. Turner, 1995.
322. E. Turner, personal communication, 1996.
323. J. Haley, personal communication, 1977.
324. Blader, J. C. (2010, October). Larger growth in U.S. acute-care hospitalization forpsychiatric disorders among youth than adults, 1996–2007. Poster presented at the AnnualMeeting of the American Academy of Child and Adolescent Psychiatry, NY.
325. Paston, P. N., Reuben, C. A. (2008). Diagnosed attention deficit hyperactivitydisorder and learning disability: United States, 2004–2006. National Centerfor Health Statistics. Vital and Health Statistics, 10 (237)
326. Centers for Disease Controland Prevention. (2010). Increasing prevalence of parent-reported attentiondeficit/hyperactivity disorder among children—United States, 2003 and 2007.Morbidity and Mortality Weekly Report, 59, 1439–1443.
327. Centers for Disease Control and Prevention. (2009). Prevalence of autismspectrum disorders—Autism and Developmental Disabilities Monitoring Network,United States, 2006. Surveillance Summaries (2006). MMWR, 58 (No. SS-10).
328. Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., Olfson, M.(2007). National trends in the outpatient diagnosis and treatment of bipolar disorderin youth. Archives of General Psychiatry, 64, 1032–1039.
329. For example, Olfson, M., Crystal, S., Huang, C., Gerhard, T. (2010). Trendsin antipsychotic drug use by very young, privately insured children. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 49, 13–23
330. Olfson, M., Marcus, S. C., Weissman, M. M., Jensen, P. S. (2002). National trends in the use of psychotropicmedications by children. Journal of the American Academy of Child and AdolescentPsychiatry, 41, 514–521.
331. Public Agenda. (2002). A lot easier said than done: Parents talk about raisingchildren in today’s America. Retrieved from www.publicagenda.org/specials/parents/parents.htm
332. Vandivere, S., Gallagher, M., Moore, K. A. (2004). Changes in children’swell-being and family environments. Snapshots of America’s families III, No. 10. NewYork: Urban Institute. Retrieved from www.urban.org/url.cfm?ID=310912
333. Jensen, P. S., Hoagwood, K. (1997). The book of names: DSM-IV in context.Development and Psychopathology, 9, 231–249
334. Jensen, Hoagwood, & Zitner, 2006. What’s in a name? Problems vs. prospects in current diagnostic approaches.In D. Cicchetti & D. J. Cohen (Eds.), Developmental psychopathology: Theory andmethod.
335. See, for example, Goodyer, I. M. (2006). The hypothalamic-pituitaryadrenalaxis: Cortisol, DHEA, and psychopathology. In M. E. Garralda & M. Flament(Eds.), Working with children and adolescents: An evidence-based approach to riskand resilience. Lanham, MD
336. Jason Aronson; Hebebrand, J., Reichwald, K., Schimmelmann, B.G., Hinney, A. (2006). Identifying genes underlying child and adolescentpsychiatric disorders. In M. E. Garralda & M. Flament (Eds.), Working withchildren and adolescents: An evidence-based approach to risk and resilience. Lanham, MD
337. Jason Aronson; Kim, Y. (Ed). (2009). Handbook of behavior genetics. New York:Springer.
338. Findling, R. L. (Ed.). (2008). Clinical manual of child and adolescent psychopharmacology.Washington, DC: American Psychiatric Publishing.
339. Rutter, M., Sroufe, L. A. (2000). Developmental psychopathology: Conceptsand challenges. Development and Psychopathology, 12, 265–295.
340. Cichetti, D., Rogosch, F. A. (1996). Equifinality and multifinality in developmentalpsychopathology. Development and Psychopathology, 8, 597–600.
341. Frick, P. J., Viding, E. (2009). Antisocial behavior from a developmentalpsychopathology perspective. Development and Psychopathology, 21, 1111–1131.
342. Cornell, A. H., Frick, P. J. (2007). The moderating effects of parentingstyles in the association between behavioral inhibition and parent-reported guiltand empathy in preschool children. Journal of Clinical Child & Adolescent Psychology, 36. 305–318.
343. Cicchetti, D. (2010). A developmental psychopathology perspective on bipolardisorder. In D. J. Milkiwitz (Ed.). Understanding bipolar disorder: A developmentalpsychopathology perspective. New York: Guilford.
344. Baker, J. K., Messinger, D. S., Lyons, K. K., Grantz, C. J. (2010). A pilotstudy of maternal sensitivity in the context of emergent autism. Journal of Autismand Developmental Disorders, 40, 988–999.
345. Baker, J. K., Smith, L. E., Greenberg, J. S., Seltzer, M. M., Taylor, J. L.(2011). Change in maternal criticism and behavior problems in adolescents andadults with autism across a 7-year period. Journal of Family Psychology, 24, 775–777
346. Smith, L. E., Greenberg, J. S., Seltzer, M. M., Hong, J. (2008). Symptoms and behaviorproblems of adolescents and adults with autism: Effects of mother-childrelationship quality, warmth, and praise. American Journal on Mental Retardation, 113. 387–402.
347. Miklowitz, D. J. (2004). The role of family systems in severe and recurrentpsychiatric disorders: A developmental psychopathology view. Development andPsychopathology, 16, 667–688.
348. Miklowitz, D. J., Axelson, D. A., Birmaher, B., George, E. L., Taylor, D. O.,Schneck, C. D.,… Brent, D. A. (2008). Family-focused treatment for adolescentswith bipolar disorder: Results of a 2-year randomized trial. Archives of General Psychiatry, 65. 1053–1061.
349. Bouchard, T. J. (2004). Genetic infl uence on human psychological traits:A survey. Current Directions in Psychological Science, 13, 148–151
350. Bouchard, T. J., &Loehlin, J. C. (2001). Genes, evolution, and personality. Behavior Genetics, 31, 243– 274.
351. Roisman, R., Fraley, C. (2006). The limits of genetic infl uence: A behaviorgeneticanalysis of infant–caregiver relationship quality and temperament. ChildDevelopment, 77, 1656–1667
352. Saudino, K. J., Cherny, S. S. (2001). Sources of continuityand change in observed temperament. In R. N. Emde & J. K. Hewitt (Eds.),Infancy to early childhood: Genetic and environmental infl uences on developmental change(pp. 89–110). New York: Oxford University Press.
353. Gregory, A. M., Eley, T. C., Plomin, R. (2004). Exploring the association betweenanxiety and conduct problems in a large sample of twins age 2–4. Journal ofAbnormal Child Psychology, 32, 111–122
354. Lemery, K. S., Doelger, L. (2005). Geneticvulnerabilities to psychopathology. In B. L. Hankin & J.R.Z. Abela (Eds.), Developmentof psychopathology: A vulnerability-stress perspective (pp. 161–198). ThousandOaks, CA: Sage.
355. Rutter, M. (2011). Biological and experiential infl uences on psychologicaldevelopment. In D. P. Keating (Ed.), Nature and nurture in early child development(pp. 7–44). New York: Cambridge University Press.
356. See, for example, Afifi, T. O., Brownridge, D. A., Cox, B. J., Sareen, J.(2006). Physical punishment, childhood abuse and psychiatric disorders. ChildAbuse and Neglect, 30, 1093–1103
357. Bender, H. L., Allen, J. P., McElhaney, K. B., Antonishak, J., Moore, C. M., Kelly, H. L., Davis, S. M. (2007). Use of harsh physicaldiscipline and developmental outcomes in adolescence. Development and Psychopathology, 19. 227–242
358. Kochanska, G., Aksan, N. (2006). Children’s conscience andself-regulation. Journal of Personality, 74, 1587–1617
359. Lynch, S. K., Turkheimer, E.,D’Onofrio, B. M., Mendle, J., Emery, R. E., Slutske, W. S., Martin, N. G. (2006). Agenetically informed study of the association between harsh punishment and offspringbehavioral problems. Journal of Family Psychology, 20, 190–198.
360. Bridgett, D. J., Gartstein, M. A., Putnam, S. P., McKay, T., Iddins, R., Robertson,C., et al. (2009). Maternal and contextual infl uences and the effect of temperamentdevelopment during infancy on parenting in toddlerhood. Infant Behaviorand Development, 32, 103–116
361. Paulussen-Hoogeboom, M. C., Stams, G J.J.M., Hermanns, J.M.A., Peetsma, T.T.D. (2007). Child negative emotionality and parentingfrom infancy to preschool: A meta-analytic review. Developmental Psychology, 43,438–453
362. Pesonen, A.-K., Räikkönen, K., Heinonen, K., Komsi, N. (2008). A transactionalmodel of temperamental development: Evidence of a relationship betweenchild temperament and maternal stress over five years. Social Development, 17, 326– 340.
363. van Aken, C., Junger, M., Verhoeven, M., van Aken, M.A.G., Deković, M.(2007). The interactive effects of temperament and maternal parenting on toddlers’externalizing behaviours. Infant and Child Development, 16, 553–572
364. van den Boom, D.C., Hoeksma, J. B. (1994). The effect of infant irritability on mother–infant interaction:A growth-curve analysis. Developmental Psychology, 30, 581–590.
365. Feldman, R., Greenbaum, C. W., &Yirmiya, N. (1999). Mother–infant affectsynchrony as an antecedent of the emergence of self-control. Developmental Psychology, 35. 223–231
366. Raikes, H. A., Robinson, J. L., Bradley, R. H., Raikes, H. H., &Ayoub, C. C. (2007). Developmental trends in self-regulation among low-incometoddlers. Social Development, 16, 128–149.
367. Cipriano, E. A., Stifter, C. A. (2010). Predicting preschool effortful controlfrom toddler temperament and parenting behavior. Journal of Applied DevelopmentalPsychology, 31, 221–230
368. Jaffari-Bimmel, N., Juffer, F., van IJzendoorn, M. H., Bakermans-Kranenburg, M. J., Mooijaart, A. (2006). Social development from infancyto adolescence: Longitudinal and concurrent factors in an adoption sample.Developmental Psychology, 42, 1143–1153.
369. Tienari, P., Wynne, L. C., Laksy, K., Moring, J., Nieminen, P., Sorri, A.,et al. (2003). Genetic boundaries of the schizophrenia spectrum: Evidence from theFinnish adoptive family study of schizophrenia. The American Journal of Psychiatry, 160. 1587–1594
370. Tienari, P., Wahlberg, K. E., Wynne, L. C. (2006). Finnish adoptionstudy of schizophrenia: Implications for family interventions. Families, Systems,and Health, 24, 442–451.
371. Plomin, R. (2005). Finding genes in child psychology and psychiatry: When are wegoing to be there? Unpublished manuscript. London: King’s College
372. Plomin, R., &Davis, O.S.P. (2009). The future of genetics in psychology and psychiatry: Microarrays,genome-wide association, and non-coding RNA. Journal of Child Psychologyand Psychiatry, 50, 63–71.
373. Ivorra, J. L., Sanjuan, J., Jover, M., Carot, J. M., de Frutos, R., Molto, M. D.(2010). Gene-environment interaction of child temperament. Journal of Developmentaland Behavioral Pediatrics, 31, 545–554.
374. Bakermans-Kranenburg, M. J., van IJzendoorn, M. H. (2007). Gene–environment interaction of the dopamine D4 receptor (DRD4) and observedmaternal insensitivity predicting externalizing behavior in preschoolers. DevelopmentalPsychobiology, 48, 406–409.
375. Bakermans-Kranenburg, M. J., van IJzendoorn, M. H. (2011). Differentialsusceptibility to rearing environment depending on dopamine-related genes: Newevidence and a meta-analysis. Development and Psychopathology, 23, 39–52.
376. Gray, M. R., Steinberg, L. (1999). Unpacking authoritative parenting: Reassessinga multidimensional construct. Journal of Marriage and the Family, 61, 574– 587.
377. Hart, C. H., Newell, L. D., Olsen, S. F. (2003). Parenting skills and social/communicative competence in childhood. In J. O. Greene & B. R. Burleson (Eds.),Handbook of communication and social interaction skills (pp. 753–797). Hillsdale, NJ:Erlbaum
378. Russell, A., Mize, J., Bissaker, K. (2002). Parent–child relationships.In P. K. Smith & C. H. Hart (Eds.), Handbook of childhood social development (pp.205–222). Oxford, UK: Blackwell.
379. Kochanska, G., Gross, J. N., Lin, M.-H., Nichols, K. E. (2002). Guilt inyoung children: Development, determinants, and relations with broader systemstandards. Child Development, 73, 461–482
380. Fowles, D. C., Kochanska, G. (2000).Temperament as a moderator of pathways to conscience in children: The contributionof electrodermal activity. Psychophysiology, 37, 863–872
381. Kochanska, G. (1997).Multiple pathways to conscience for children with different temperaments: Fromtoddlerhood to age 5. Developmental Psychology, 33, 228–240.
382. Baumrind, D., Black, A. E. (1967). Child care practices anteceding threepatterns of preschool behavior. Genetic Psychology Monographs, 75, 43–88; Gray andSteinberg, Unpacking authoritative parenting
383. Herman, M. R., Dornbusch, S. M.,Herron, M. C., Herting, J. R. (1997). The influence of family regulation, connection, and psychological autonomy on six measures of adolescent functioning.Journal of Adolescent Research, 12, 34–67
384. Luster, T., McAdoo, H. (1996). Familyand child infl uences on educational attainment: A secondary analysis of theHigh/Scope Perry Preschool data. Developmental Psychology, 32, 26–39
385. Mackey, K., Arnold, M. K., Pratt, M. W. (2001). Adolescents’ stories of decision making inmore and less authoritative families: Representing the voices of parents in narrative.Journal of Adolescent Research, 16, 243–268
386. Steinberg, L. D., Darling, N. E., &Fletcher, A. C. (1995). Authoritative parenting and adolescent development: Anecological journey. In P. Moen, G. H. Elder, Jr. & K. Luscher (Eds.), Examining livesin context (pp. 423–466). Washington, DC: American Psychological Association.
387. Steinberg, L. (2001). We know some things: Parent–adolescent relationshipsin retrospect and prospect. Journal of Research on Adolescence, 11, 1–19
388. Chen, X., Dong, Q., Zhou, H. (1997). Authoritative and authoritarian parenting practicesand social and school performance in Chinese children. International Journalof Behavioral Development, 21, 855–873
389. Chen, X., Liu, M., Li, D. (2000). Parentalwarmth, control, and indulgence and their relations to adjustment in Chinesechildren: A longitudinal study. Journal of Family Psychology, 14, 401–419
390. Mantzicopouilos, P. Y., Oh-Hwang, Y. (1998). The relationship of psychosocial maturityto parenting quality and intellectual ability for American and Korean adolescents.Contemporary Educational Psychology, 23, 195–206.
391. Rohner, R. P., Rohner, E. C. (1981). Parental acceptance-rejection and parentalcontrol: Cross-cultural codes. Ethnology, 20, 245–260.
392. Pettit, G. S., Bates, J. E., Dodge, K. A. (1997). Supportive parenting, ecologicalcontext, and children’s adjustment: A seven-year longitudinal study. ChildDevelopment, 68, 908–923.
393. Straus, M. A., Stewart, J. H. (1999). Corporal punishment by Americanparents: National data on prevalence, chronicity, severity, and duration, in relationto child and family characteristics. Clinical Child and Family Psychology Review, 2. 55–70
394. Gershoff, E. T. (2002). Corporal punishment by parents and associated childbehaviors and experiences: A meta-analytic and theoretical review. PsychologicalBulletin, 128, 539–579.
395. Brezina, T. (1999). Teenage violence toward parents as an adaptation tofamily strain: Evidence from a national survey of male adolescents. Youth & Society, 30. 416–444
396. Gershoff, E. T. (2002). Corporal punishment by parents and associatedchild behaviors and experiences: A meta-analytic and theoretical review.Psychological Bulletin, 128, 539–579.
397. Lansford, J. E., Criss, M. M., Dodge, K. A., Shaw, D. S., Pettit, G. S., Bates, J. E. (2009). Trajectories of physical discipline: Early childhood antecedents and developmentaloutcomes. Child Development, 80, 1385–1402.
398. Berlin, L. J., Ipsa, J. M., Fine, M. A., Malone, P. S., Brooks-Gunn, J., Brady-Smith, C., et al. (2009). Correlates and consequences of spanking and verbalpunishment for low-income white, African-American, and Mexican-Americantoddlers. Child Development, 80, 1403–1420
399. Erath, S. A., Bierman, K. L., the ConductProblems Prevention Research Group. (2006). Aggressive marital conflict,maternal harsh punishment, and child aggressive-disruptive behavior: Evidencefor direct and mediate relations. Journal of Family Psychology, 20, 217–226
400. Taylor, C. A., Manganello, J. A., Lee, S. J., Rice, J. C. (2010). Mothers’ spanking of 3-yearoldchildren and subsequent risk of children’s aggressive behavior. Pediatrics, 125,e1057–e1065.
401. For a comprehensive review of these interventions, and the research basesupporting them, see Roberts, M. W. (2008). Parent training. In M. Hersen & A. M.Gross (Eds.). Handbook of clinical Psychology, Volume 2: Children and adolescents (pp.653–693). Hoboken, NJ: John Wiley & Sons.
402. See, for example, Hembree-Kigin, T. L. & McNeil, C. B. (1995). Parent-childinteraction therapy. New York: Plenum Press
403. McMahon, R. J. & Forehand, R. L.(2003). Helping the noncompliant child (2nd. New York: Guilford Press.
404. Kochanska, G., Forman, D. R., Aksan, N., Dunbar, S. B. (2005). Pathwaysto conscience: Early mother-child mutually responsive orientation and children’smoral emotion, conduct, and cognition. Journal of Child Psychology and Psychiatry
405. 19–34; Kochanska, G., Barry, R. A., Aksan, N., Boldt, L. J. (2008). A developmentalmodel of maternal and child contributions to disruptive conduct: The firstsix years. Journal of Child Psychology and Psychiatry, 49, 1220–1227.
406. Ladd, G. W., LeSieur, K., Profilet, S. M. (1993). Direct parental infl uenceson young children’s peer relations. In S. Duck (Ed.), Learning about relationships(Vol. 2, pp. 152–183). London: Sage
407. Laird, R. D., Pettit, G. S., Mize, J., Lindsey, E. (1994). Mother–child conversations about peers: Contributions to competence.Family Relations, 43, 425–432
408. Mize, J., Pettit, G. S. (1997). Mothers’ socialcoaching, mother–child relationship style, and children’s peer competence: Is themedium the message? Child Development, 68, 312–332.
409. Russell, A., Pettit, G. S., Mize, J. (1998). Horizontal qualities in parent–child relationships: Parallels with and possible consequences for children’s peerrelationships, Developmental Review, 18, 313–352
410. Lindsey, E. W., Mize, J. (2000).Parent–child physical and pretense play: Links to children’s social competence.Merrill-Palmer Quarterly, 46, 1479–1498
411. Pettit, G. S., Brown, E. G., Mize, J., Lindsey, E. (1998). Mothers’ and fathers’ socializing behaviors in three contexts: Linkswith children’s peer competence. Merrill-Palmer Quarterly, 44, 385–394.
412. Mounts, N. S., Steinberg, L. (1995). An ecological analysis of peer infl uenceon adolescent grade point average and drug use. Developmental Psychology, 31. 915–922.
413. Furman, W., Simon, V. A., Shaffer, L., Bouchey, H. A. (2002). Adolescents’working models and styles for relationships with parents, friends, and romanticpartners. Child Development, 73, 241–255.
414. Fletcher, A. C., Darling, N. E., Steinberg, L., Dornbusch, S. M. (1995). Thecompany they keep: Relation of adolescents’ adjustment and behavior to theirfriends’ perceptions of authoritative parenting in the social network. DevelopmentalPsychology, 31, 300–310
415. Mason, C. A., Cauce, A. M., Gonzales, N., Hiraga, Y.(1996). Neither too sweet nor too sour: Problem peers, maternal control, and problembehavior in African American adolescents. Child Development, 67, 2115–2130.
416. Sim, T. N. (2000). Adolescent psychosocial competence: The importanceand role of regard for parents. Journal of Research on Adolescence, 10, 49–64.
417. Fuligni, A. J., Eccles, J. S. (1993). Perceived parent–child relationships andearly adolescents’ orientation toward peers. Developmental Psychology, 29, 622–632.
418. Hoeve, M., Dubas, J. S., Eichelsheim, V. I., van der Laan, P. H., Smeenk, W., &Gerris, J.R.M. (2009). The relationship between parenting and delinquency: Ameta-analysis. Journal of Abnormal Child Psychology, 37, 749–775
419. Laird, R. D., Criss, M. M., Pettit, G. S., Dodge, K. A., Bates, J. E. (2008). Parents’ monitoring knowledgeattenuates the link between antisocial friends and adolescent delinquent behavior.Journal of Abnormal Child Psychology, 36, 299–310
420. McCoy, S. I., Jewell, N. P.,Hubbard, A., Gerdts, C. E., Doherty, I. A., Padian, N. S., Minnis, A. M. (2010). Atrajectory analysis of alcohol and marijuana use among Latino adolescents in SanFrancisco, California. Journal of Adolescent Health, 47, 564–574.
421. See Crouter, A. C., Head, M. R. (2002). Parental monitoring and knowledgeof children. In M. H. Bornstein (Ed.), Handbook of parenting : Vol. 3. Being andbecoming a parent (2nd, pp. 461–483). Mahwah, NJ: Erlbaum.
422. Dick, D., Latendresse, S. J., Lansford, J. E., Budde, J. P., Goate, A., Dodge, K. A.,… Bates, J. E. (2009). Role of GABRA2 in trajectories of externalizing behavioracross development and evidence of moderation by parental monitoring. Archivesof General Psychiatry, 66, 649–658.
423. Véronneau, M. & Dishion, T. J. (2010). Predicting change in early adolescentproblem behavior in the middle school years: A mesosystemic perspective on parentingand peer experiences. Journal of Abnormal Child Psychology, 38, 1125–1137.
424. See, for example, Dishion, T. J., Nelson, S. E., Kavanagh, K. (2003). Thefamily check-up with high-risk young adolescents: preventing early onset substanceuse by parent monitoring. Behavior Therapy, 34, 553–571
425. Schinke, S. P., Fang, L., Cole, K. C. (2009). Computer-delivered parent involvement intervention toprevent substance use among adolescent girls. Preventive Medicine, 49, 429–435.
426. Gottman, J. & DeClaire, J. (1997). Raising an emotionally intelligent child. NewYork: Fireside, p. 21.
427. Ramsden, S. R., Hubbard, J. A. (2002). Family expressiveness andparental emotion coaching: Their role in children’s emotion regulation and aggression
428. Shortt, J. W., Stoolmiller, M., Smith-Shine, J. N., Eddy, J. M., Sheeber, L.(2010). Maternal emotion coaching, adolescent anger regulation, and siblings’ externalizingsymptoms. Journal of Child Psychology and Psychiatry, 51, 799–808.
429. Gottman, J., Katz, L., Hooven, C. (1996). Meta-emotion: How families communicateemotionally, links to child peer relations and other developmental outcomes.Mahwah, NJ: Lawrence Erlbaum.
430. Katz, L. F., Windecker-Nelsen, B. (2006). Domestic violence, emotioncoaching, and child aggression. Journal of Family Psychology, 20, 56–67.
431. Havinghurst, S. S., Wilson, K. R., Harley, A. E., Prior, M. R., Kehoe, C.(2010). Tuning in to kids: Improving socialization practices in parents of preschoolchildren—findings from a community trial. Journal of Child Psychology and Psychiatry, 51. 1342–1350.
432. Connell, A. M., Goodman, S. H. (2002). The association between psychopathologyin fathers versus mothers and children’s internalizing and externalizingbehavior problems: A meta-analysis. Psychological Bulletin, 128, 746–773.
433. See, for example, Goodman, S. H., Gottlib, J. H. (1999). Risk for psychopathologyin the children of depressed mothers: A developmental model for understandingmechanisms of transmission. Psychological Review, 106, 458–490.
434. Garber, J., Ciesla, J. A., McCauley, E., Diamond, G. (2011). Remission ofdepression in parents: Links to health functioning in their children. Child Development, 82. 226–243.
435. Riley, A. W., Valdez, C. R., Barrueco, S., Mills, C., Beardslee, W., Sandler, I., &Rawal, P. (2008). Development of a family-based program to reduce risk and promoteresilience among families affected by maternal depression: Theoretical basisand program description. Clinical Child and Family Psychology Review, 11, 12–29.
436. Valdez, C. R., Mills, C. L., Barrueco, S., Leis, J., Riley, A. (2011). A pilotstudy of a family-focused intervention for children and families affected by maternaldepression. Journal of Family Therapy, 33, 3–19.
437. Hetherington, E. M., Stanley-Hagan, M. (2002). Parenting in divorced andremarried families. In M. H. Bornstein (Ed.), Handbook of parenting : Vol. 3. Beingand becoming a parent (2nd, pp. 287–315). Mahwah, NJ: Erlbaum; Federal InteragencyForum on Child and Family Statistics. (2009). America’s children: Key nationalindicators of well-being, 2009. Washington, DC: U.S. Government Printing Office.
438. Amato, P. R. (2001). Children of divorce in the 1990s: An update of theAmato and Keith (1991) meta-analysis. Journal of Family Psychology, 15, 355–370
439. Wolfinger, N. H. (2000). Beyond the intergenerational transmission of divorce: Dopeople replicate the patterns of marital instability they grew up with? Journal ofFamily Issues, 21, 1061–1086.
440. Amato, Children of divorce in the 1990s; Kunz, J. (2001). Parental divorceand children’s interpersonal relationships: A meta-analysis. Journal of Divorce andRemarriage, 34, 19–47
441. Reifman, A., Villa, L. C., Amans, J. A., Rethinam, V., Telesca, T. Y. (2001). Children of divorce in the 1990s: A meta-analysis. Journal of Divorce& Remarriage, 36, 27–36.
442. Forgatch, M. S., DeGarmo, D. S. (1999). Parenting through change: Aneffective prevention program for single mothers. Journal of Consulting and ClinicalPsychology, 67, 711–724.
443. Wolchik, S. A., Sandler, I. N., Millsap, R. E., Plummer, B. A., Greene, S. M.,Anderson, E. R.,… Haine, R. A. (2003). Six-year follow-up of preventive interventionsfor children of divorce: A randomized controlled trial. Journal of the AmericanMedical Association, 288, 1874–1881.
444. Hirschi, T. (2004). Self-control and crime. In R. F. Baumeister & K. D. Vohs(Eds.), Handbook of self-regulation: Research, theory and applications. New York: GuilfordPress
445. Gottfredson, M. R., Hirschi, T. (1990). A general theory of crime. Stanford,CA: Stanford University Press.
446. Tremblay, R. E., Hartup, W. W., Archer, J. (Eds.). (2005). Developmental originsof aggression. New York: The Guilford Press.
447. http://www.pnas.org/cgi/doi/10.1073/pnas.1010076108i8
448. Shanker, S., Casenhiser, D., Stieben, J. (2011). Understanding the nature ofself-regulation. Manuscript submitted for publication.
449. http://www.environmentalhealth.ca/fall08brain.html
450. Field, T. (2007). The amazing infant. New York: Wiley-Blackwell.
451. http://www.mflmarmac.k12.ia.us/School%20Website/high_school/student_gallery/writing/family_decline.htm
452. Hirsch-Pasek, K., Golinkoff, M., Berk, L., Singer, D. (2008). A mandate forplayful learning in preschool: Applying the scientific evidence. New York: Oxford UniversityPress.
453. Louv, R. (2005). Last child in the woods. New York: Algonquin Books.
454. Ratey, J. R. (2008). Spark: The revolutionary new science of exercise and the brain.New York: Little, Brown & Co.
455. Staples, A. D. & Bates, J. E. (in press). Children’s sleep deficits and cognitiveand behavioral adjustment. In M. El-Sheikh (Ed.), Sleep and development: Familialand socio-cultural considerations.
456. Shanker, S. (in press). Emotion regulation through the ages. In A. Foolen, U. Luedke, J. Zlatev, & T. Racine (Eds.), Moving ourselves, moving others: The role of(e)motion in intersubjectivity, consciousness and language. London: John Benjamins.
457. Mischel, W., Shoda, Y., Rodriguez, M. L. (1989). Delay of gratification inchildren. Science, 244, 933–938.
458. Lewis, M. D., Granic, I., Lamm, C., Zelazo, P. D., Stieben, J., Todd, R. M.,… Pepler, D. (2008). Changes in the neural bases of emotion regulation associatedwith clinical improvement in children with behavior problems. Developmentand Psychopathology, 20 (03), 913–939.
459. Robinson, C., Mandleco, B., Olsen, S. F., Hart, C. H. (1995). Authoritative,authoritarian, and permissive parenting practices: Development of a new measure.Psychological Reports, 77, 819–830.
460. O’Keefe, M. (2005, April). Teen dating violence: A review of risk factors and preventionefforts. Harrisburg, PA: VAWnet, a project of the National Resource Centeron Domestic Violence/Pennsylvania Coalition Against Domestic Violence. Retrievedfrom: http://www.vawnet.org
461. Mahler, M., Pine, F., Bergman, A. (1973). The Psychological Birth of theHuman Infant. New York: Basic Books.
462. Bradley, S. (2000). Affect regulation and the development of psychopathology.New York: Guilford Press.
463. Cloninger, C. R. (1987). Neurogenetic adaptive mechanisms in alcoholism.Science, 236, 410–416.
464. Schore, A. (1994). Affect regulation and the origin of the self. New York: PsychologyPress.
465. Greenspan, S. I. (1979). Intelligence and adaptation: an integration of psychoanalyticand Piagetian developmental psychology. New York: International UniversitiesPress
466. Greenspan, S. I., Greenspan, N. T. (1981). The Clinical interview ofthe child. New York: McGraw-Hill
467. Greenspan, S. I. (1989). The development of theego: implications for personality theory, psychopathology, and the psychotherapeuticprocess. Madison, CT: International Universities Press
468. Greenspan, S. I.(1997). Developmentally based psychotherapy. Madison, CT: International UniversitiesPress.
469. Schunk, D. H., Ertmer, P. A. (2000). Self-regulation and academic learning:self-efficacy enhancing interventions. In M. Boekaerts, P. R. Pintrich, & M. Zeidner(Eds.), Handbook of self-regulation (pp. 631–649). San Diego: Academic Press.
470. Campos, J. J., Mumme, D. L., Kermoian, R., Campos, R. G. (1994). A functionalistperspective on the nature of emotion (pp. 284–303). Monographs of the Societyfor Research in Child Development, 59 (2–3, Serial No. 240).
471. Panksepp, J. (1998). Affective neuroscience: the foundations of human and animalemotions. New York: Oxford University Press.
472. Greenspan, S. I. (1997). The growth of the mind and the endangered origins of intelligence.Reading, MA: Addison-Wesley.
473. Greenspan, S., Shanker, S. The first idea: How symbols, language and intelligenceevolved from our primate ancestors to modern humans. Jackson, TN: Da CapoPress, Perseus Books, 2004.
474. Porges, S. (2011). The polyvagal theory: Neurophysiological foundations of emotions,attachment, communication and self-regulation. New York: W.W. Norton.
475. Duhn, L. (2010). The importance of touch in the development of attachment.Advances in Neonatal Care, (10), 294–300.
476. Wenar, C. (1982). On negativism. Human Development, 2, 1–23.
477. Zajonc, R. B. (1998). Emotions. In D. T. Gilbert, S. T. Fiske & G. Lindzey(Eds.), The handbook of social psychology (4th, Vol. 2, pp. 591–632). Boston:McGraw-Hill.
478. Goodenough, F. L. (1931). Anger in young children. Institute for Child WelfareMonographs. Minneapolis: University of Minnesota Press.
479. Greenspan, S. I. & Lewis, N. B. (2000). Building healthy minds. Cambridge,MA: Da Capo/Perseus Books.
480. Casenhiser, D., Shanker, S., Stieben, J.(in press). Learning through interaction.Autism.
481. http://www.parl.gc.ca/Content/SEN/Committee/392/soci/rep/rep08feb08-e.pdf
482. kidshavestresstoo.ph p
483. Gordon, M. (2007). Roots of empathy: Changing the world child by child.Markham, ON: Thomas Allen Publishers.
484. Diamond, A., Barnett, W. S., Thomas, J., Munro, S. (2007, November 30).Preschool program improves cognitive control. Science 318, 1387–1388 + 24 pp.Supplemental Online Material. Retrieved from http://www.sciencemag.org/cgi/content/full/317/5838/1387/DC1
485. Louv, Last child in the woods ; Ratey, Spark.